Evidence map›Paper›PMID 40814038›Full record

ArticleHemodialysis international. International Symposium on Home Hemodialysis2026

Post-Hemodialysis Flow-Dependent Hepatic Function Impairment in Individuals With End Stage Kidney Disease and Chronic Inflammation.

Oscar Swift, Bobby V M Dasari, Malcolm A Finkelman, Yonglong Zhang, Sivakumar Sridharan, Enric Vilar, Ken Farrington

Abstract read
In one paragraph

Article in Hemodialysis international. International Symposium on Home Hemodialysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oscar SwiftSchool of Life and Medical Science, University of Hertfordshire, Hatfield, Hertfordshire, UK.ORCID https://orcid.org/0000-0001-9129-8276
Bobby V M DasariDepartment of Hepatopancreatobiliary and Liver Transplant Surgery, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, West Midlands, UK.
Malcolm A FinkelmanAssociates of Cape Cod Inc., East Falmouth, Massachusetts, USA.
Yonglong ZhangAssociates of Cape Cod Inc., East Falmouth, Massachusetts, USA.
Sivakumar SridharanSchool of Life and Medical Science, University of Hertfordshire, Hatfield, Hertfordshire, UK.
Enric VilarSchool of Life and Medical Science, University of Hertfordshire, Hatfield, Hertfordshire, UK.
Ken FarringtonSchool of Life and Medical Science, University of Hertfordshire, Hatfield, Hertfordshire, UK.

Funding

East and North Hertfordshire Hospitals CharityNational Institute for Health and Care Research
6 · The paper itself

Abstract

introductionThe liver plays an important role to prevent translocation of gut-derived toxins from the portal to the systemic circulation. Chronic inflammation is common in patients receiving hemodialysis, and increased gut permeability to microbial material has been implicated in its pathogenesis. This study sought to establish if flow-dependent hepatic function was impaired in chronically inflamed individuals treated with hemodialysis.

methodsFifty adults receiving outpatient hemodialysis were recruited. Subjects with known liver or gastrointestinal disease, acute inflammation, and hemodynamic instability during hemodialysis were excluded. Participants were divided into two groups (n = 25): individuals with chronic inflammation (defined as a median high-sensitivity C-reactive protein (hs-CRP) ≥ 5 mg/dL over the preceding 3 months) with no apparent cause and a noninflamed group. Flow-dependent hepatic function (defined as a composite of hepatic perfusion, hepatocyte clearance and biliary excretion) was assessed following hemodialysis by indocyanine green clearance to derive: (1) indocyanine green-plasma disappearance rate and (2) indocyanine green-retention after 15 min. Serum beta-D-glucan levels pre- and post-hemodialysis were measured as surrogate markers of gastrointestinal permeability.

findingsIndocyanine green-plasma disappearance rate was reduced in the inflamed group versus the noninflamed group (19.4 (8.7)%/min vs. 23.8 (14.4)%/min; p = 0.02). Indocyanine green-retention after 15 min was higher in the inflamed group (5.4 (6.8)% vs. 2.9 (5.0)%; p = 0.02). Noninvasive hepatic fibrosis and steatosis assessments were similar in both groups. Pre-hemodialysis beta-D-glucan levels were similar (63 (42) pg/ml vs. 49 (11) pg/ml; p = 0.13), whereas post-hemodialysis beta-D-glucan levels were higher in the inflamed group (82 (48) pg/ml vs. 58 (27) pg/ml; p < 0.001), and in those with flow-dependent hepatic impairment (72 (45) vs. 55 (32) pg/ml; p = 0.004). In linear regression analysis, indocyanine green-retention after 15 min and post-hemodialysis beta-D-glucan levels were independent predictors of median hs-CRP, explaining 21% of the variation. DISCUSSION: Individuals with otherwise unexplained inflammation had impaired hepatic function post-hemodialysis and higher post-hemodialysis beta-D-glucan levels. These findings are compatible with the notion that impaired hepatic gut-derived toxin removal propagates chronic inflammation in hemodialysis.

Indexed as

InflammationKidney Failure, ChronicLiverRenal DialysisAdultAgedChronic DiseaseFemaleHumansLiver Function TestsMaleMiddle Agedbeta‐D‐glucanchronic inflammationhepatic function

Identifiers

PMID40814038
PMCPMC12817157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.